The Wellcome Trust’s Jeremy Farrar is all but begging for action to shore up the failing antibiotics market. Decades of weak investment in antibiotics has left “perilously few” companies involved in antibiotic development—a market crisis unfolding alongside the rise of deadly drug-resistant superbugs. Farrar warns that there is currently no viable pathway to market […]
Tag: pharmaceuticals
In The Middle Of It: U.S. Scrutinizes Pharma Benefits Managers
In case anyone was wondering, it’s never good to be identified as a “middleman.” That’s the label being applied to pharmacy benefits managers who are being blamed for jacking up pharmaceutical prices through opaque agreements with pharmaceutical manufacturers and insurers, which allow the PBMs to negotiate substantial discounts without passing the savings along to […]